etoposide,pembrolizumab
merck
['biomarker', 'etoposide', 'keynote-604', 'mds', 'pembro', 'sclc', 'lcsm,(-blcsm)']
exploratory biomarker analysis of the phase 3 keynote-604 study of pembrolizumab plus etoposide for extensive-stage sclc presented by mmdsc and gmdsc is an interesting finding that deserves confirmation. #lcsm #asco23 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm